Jamaican Scientists Are Creating Affordable Hepatitis C Drug From Weed

A group of Caribbean scientists has reportedly made a major breakthrough in using cannabidiol (CBD) – an active compound in cannabis – to treat hepatitis C. The discovery The effort is being led by leading Jamaican cancer researcher Dr. Henry Lowe, whose team at the University of the West Indies made the announcement.

The discovery

which is fleshed out in greater detail in the latest issue of the peer-reviewed publication Pharmacognosy Research – could provide vital treatment for the hepatitis C. The illness has been linked to causing cirrhosis of the liver, as well as liver cancer. the development is a major medicinal breakthrough in both treating the illness and saving patients exorbitant amounts of money on medical expenses.

Doctor’s orders

This is a new discovery which has fantastic potential for the future, especially for people in developing countries, because there is a drug which was developed for hepatitis C treatment, but it’s over US$85,000 per treatment and very few people in the developing world can afford this.

The doctor noted that most cases of the disease occur in the developing world and that he is hopeful the substance could be available in the relatively near future.

We’re hoping that by next year, with the data we have, we should be able to go to clinical trials. So it’s a major, major new development.

Dr. Lowe also mentioned that talks are occurring with the government of South Africa to widen the scope of research into medical cannabis, potentially paving the way for even greater discoveries down the road.

Hepatitis C

It makes sense that Dr. Lowe places emphasis on finding hepatitis C treatment for those afflicted in developing nations: According to the data, those are the areas that are in the direst need of a solution to the problem.

Data from the World Health Organization indicates that the areas of the world most affected by the condition are Africa and Central and East Asia.

Around 2-3 percent of people around the world – between 130-170 million – are believed to be afflicted with the disease. In all, between 350,000 and 500,000 people are believed to die each year from the illness and its ancillary conditions.

 

  • What is your oppinion? Leave a comment below